107 related articles for article (PubMed ID: 6957713)
1. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
DuVernay VH; Eubanks D; Perales R; Prestayko AW; Crooke ST
Mol Pharmacol; 1982 Jan; 21(1):196-203. PubMed ID: 6957713
[TBL] [Abstract][Full Text] [Related]
2. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
[No Abstract] [Full Text] [Related]
3. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
4. DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule.
DuVernay VH; Pachter JA; Crooke ST
Mol Pharmacol; 1979 Sep; 16(2):623-32. PubMed ID: 514262
[No Abstract] [Full Text] [Related]
5. Antitumor agents from bohemic acid complex, III. The isolation of marcellomycin, musettamycin, rudolphomycin, mimimycin, collinemycin, alcindoromycin, and bohemamine.
Nettleton DE; Balitz DM; Doyle TW; Bradner WT; Johnson DL; O'Herron FA; Schreiber RH; Coon AB; Moseley JE; Myllymaki RW
J Nat Prod; 1980; 43(2):242-58. PubMed ID: 7381507
[TBL] [Abstract][Full Text] [Related]
6. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
7. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
Steinheider G; Westendorf J; Marquardt H
Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
[TBL] [Abstract][Full Text] [Related]
8. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
Schwartz HS; Kanter PM
Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
Meriwether WD; Bachur NR
Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
[No Abstract] [Full Text] [Related]
14. Effect of anthracycline analogues on the appearance of newly synthesized total RNA and messenger RNA in the cytoplasm of erythroleukemia cells.
Long BH; Willis CE; Prestayko AW; Crooke ST
Mol Pharmacol; 1982 Jul; 22(1):152-7. PubMed ID: 6956804
[TBL] [Abstract][Full Text] [Related]
15. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
Yoshida M; Khokhar AR; Siddik ZH
Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
[TBL] [Abstract][Full Text] [Related]
17. The structural basis for anthracycline antibiotic stimulation of oxygen consumption by HL-60 cells and mitochondria.
Burke TG; Pritsos CA; Sartorelli AC; Tritton TR
Cancer Biochem Biophys; 1987 Sep; 9(3):245-55. PubMed ID: 3124953
[TBL] [Abstract][Full Text] [Related]
18. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
19. Antitumor mechanisms of zinostatin stimalamer (YM881).
Tanaka S; Yamamoto M; Numasaki Y
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety.
Ciesielska E; Studzian K; Wasowska M; Oszczapowicz I; Szmigiero L
Cell Biol Toxicol; 2005; 21(3-4):139-47. PubMed ID: 16328893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]